Synapse - Works

Results (51)

Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer

Journal Article

Ehmann, S.; Lam, C.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; Long Roche, K.; Zivanovic, O.; Sonoda, Y.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Journal Article

Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction

Journal Article

Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
American Journal of Roentgenology (2023)

Fulltext@MSK | Save

Germline drivers of gynecologic carcinosarcoma

Meeting Abstract

Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer

Meeting Abstract

Praiss, A.; Moukarzel, L.; Zhu, Y.; Derakhshan, F.; Hoang, T.; Pesci, G.; Green, H.; Hanlon, E.; Gardner, G.; Roche, K. L.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Leave it in the past: Primary treatment modality for high-grade epithelial ovarian cancer does not affect secondary cytoreduction outcomes

Meeting Abstract

Manning-Geist, B.; Sia, T.; Ehmann, S.; Luardo, C.; Praiss, A.; Lavery, J.; Iasonos, A.; Sonoda, Y.; Grisham, R.; Zivanovic, O.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

My individualized risk reduction for ovarian cancer (MIRROR): Development of a patient decision aid for risk-reducing surgery in hereditary risk for ovarian cancer

Meeting Abstract

Feinberg, J.; Gordhandas, S.; Austria, M.; Carlsson, S.; Abu-Rustum, N.; Liu, Y.; Roche, K. L.
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival

Meeting Abstract

Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Leave it in the past - Primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study

Journal Article

Sia, T. Y.; Manning-Geist, B. L.; Ehmann, S.; Lavery, J. A.; Luardo, C.; Praiss, A.; Iasonos, A.; Sonoda, Y.; Grisham, R. N.; Liu, Y. L.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Journal Article

Manning-Geist, B. L.; Kahn, R. M.; Nemirovsky, D.; Girshman, J.; Laibangyang, A.; Gordhandas, S.; Iasonos, A.; Chui, M. H.; Long Roche, K.; Zivanovic, O.; more...
Cancer (2023)

Fulltext@MSK | Save